Home › Funds › Maple Capital Management, Inc. › JNJ

Maple Capital Management, Inc. position in JNJ

JOHNSON & JOHNSON · Health Care

Maple Capital Management, Inc. reported holding 166,950 shares of JNJ (JOHNSON & JOHNSON) in its Q3 2026 13F filing — a position valued at US$44.2M, representing 2.85% of its reported portfolio and ranking #12 among its reported holdings. Maple Capital Management, Inc. has disclosed JNJ holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)166.95K sh
Reported value held$44.20M
Portfolio Weight2.85%
First reportedQ3 2023
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Maple Capital Management, Inc.'s JNJ position evolved

Maple Capital Management, Inc. first disclosed a stake in JNJ in Q3 2023 at 153,542 shares (US$23.9M). The position peaked in Q3 2026 at 166,950 shares, worth US$44.2M. Across 13 filings, Maple Capital Management, Inc. increased the stake 7 time(s), trimmed it 3 time(s) and left it unchanged 2 time(s). The most recent filing (Q3 2026) shows 166,950 shares valued at US$44.2M — a reduction of -3,845 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q3 2023 153.54K $23.91M New
Q4 2023 156.81K $24.58M Add
Q1 2024 161.14K $25.49M Add
Q2 2024 164.40K $24.03M Add
Q3 2024 166.40K $26.97M Add
Q4 2024 166.23K $24.04M Hold
Q1 2025 167.98K $27.86M Add
Q2 2025 171.85K $26.25M Add
Q3 2025 174.21K $32.30M Add
Q4 2025 174.83K $36.18M Hold
Q1 2026 171.98K $42.04M Reduce
Q2 2026 170.79K $43.38M Reduce
Q3 2026 166.95K $44.20M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About JNJ and 13F data

JNJ (JOHNSON & JOHNSON) is a Health Care company. 32 other funds we track also report a position in JNJ — the largest reported positions include BlackRock Inc (US$53.87B), Vanguard Group (US$49.74B), VANGUARD CAPITAL MANAGEMENT LLC (US$41.76B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding JNJ

All JNJ fund holders →

FAQ

How long has Maple Capital Management, Inc. held JNJ?

Maple Capital Management, Inc. has disclosed JNJ holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Maple Capital Management, Inc.'s current position in JNJ?

As of Q3 2026, Maple Capital Management, Inc. holds 166.95K shares of JNJ (JOHNSON & JOHNSON), valued at $44.20M, representing 2.85% of its reported portfolio and ranking #12.

Has Maple Capital Management, Inc. been buying or selling JNJ?

In the latest 13F filing (Q3 2026), Maple Capital Management, Inc. reduced its position in JNJ. The position peaked in Q3 2026 at 166.95K shares.

Which other funds hold JNJ?

Other major institutional holders of JNJ include BlackRock Inc, Vanguard Group, VANGUARD CAPITAL MANAGEMENT LLC, among 32 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.